Global Continuous Glucose Monitoring Systems Market is estimated to flourish at a compound annual growth rate (CAGR) of 22.9% by 2024
A recent report by KD market insights titled as "Continuous Glucose Monitoring Systems Market Size, Trends &
Opportunity Outlook – Forecast to 2024" provides the key
trends, opportunities and challenges market will face in the forecasted period
of 6 years i.e. 2016-2024. The study also provides the Continuous Glucose Monitoring Systems Market. competitors share
and region wise analysis around the globe.
Continuous glucose
monitoring (CGM) is one of the latest technological advancements in the field
of diabetes management. CGM system is a type of glucose monitoring device that
functions by inserting a biosensor through transcutaneous or subcutaneous
route. The embedded sensor measures the glucose levels in interstitial fluid or
blood, and transmits the information using a transmitter to a receiver/monitor
for displaying the results. These systems play an integral role in diabetes
management, owing to their associated several advantages over other glucose
monitoring devices. Unlike conventional glucose monitors, these systems enable
periodic monitoring of glucose levels, which is crucial for avoiding diabetic
complications. In addition, CGMS technology has laid a roadmap to the most
awaited, high-tech, closed-loop artificial/bionic pancreas. Therefore,
development of novel and technologically advanced CGMS is the prime focus of
glucose monitoring device manufacturing companies. It offers a wide range of
applications for all age-cohorts, healthcare settings (diagnostic
centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus,
CGMS market poses lucrative opportunity for both CGMS manufacturers and insulin
pump manufacturers.
The global CGMS
market generated $894 million in 2016, and is projected to reach
$4,921 million by 2024, registering a CAGR of 22.9% during the
forecast period. The pipeline of high-tech CGMS devices, such as
smartphone-connected CGMS, wearable & smartphone-connected CGMS,
non-invasive CGMS and ‘smart’ diabetes management solution (also called
artificial/bionic pancreas), is expected to result in higher adoption of CGMS
among endocrinologists and patients.
The market is categorized
based on component, demographics, end user, and region. The CGMS components
market includes durable components such as transmitters & receivers and
integrated insulin pumps; and disposable components such as sensors. The
segment for sensors occupies a dominant share in the CGMS market due to
recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is
deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in
hospital ICUs and in-home healthcare settings has increased in the recent
years. On the basis of demographics, CGMS devices are categorized into child
population (≤14 years) and adult population (>14 years).
The report includes
comprehensive geographical analysis and segmentation of geographical regions,
which include North America, Europe, Asia-Pacific, and LAMEA. The major
strategies adopted by market players are collaborations, product launches, and
product approvals. The adoption of collaboration strategy by companies enables
greater focus on innovation, distribution, and commercialization of devices.
KEY BENEFITS
- This report provides an
extensive analysis of the current and emerging trends, and dynamics in the
global CGMS market to identify the prevailing opportunities.
- It presents a competitive landscape of the global market to predict the market scenario across geographies.
- A comprehensive analysis of factors that drive and restrict the market growth is provided.
- The region- and country-wise analyses are provided to understand the market trends and dynamics.
- It presents a competitive landscape of the global market to predict the market scenario across geographies.
- A comprehensive analysis of factors that drive and restrict the market growth is provided.
- The region- and country-wise analyses are provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Component
- Sensors
- Transmitters & Receivers
- Integrated Insulin Pumps
- Transmitters & Receivers
- Integrated Insulin Pumps
By Demographics
- Child Population (14
years)
- Adult Population (>14 years)
- Adult Population (>14 years)
By End User
- Diagnostics &
Clinics
- ICUs
- Home Healthcare
- ICUs
- Home Healthcare
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Norway
- Sweden
- Denmark
- Finland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Venezuela
- Argentina
- Rest of LAMEA
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Norway
- Sweden
- Denmark
- Finland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Venezuela
- Argentina
- Rest of LAMEA
The key players
profiled in this report are as follows:
- Abbott Laboratories
- Dexcom, Inc.
- A. Menarini Diagnostics
- Echo Therapeutics, Inc.
- GlySens Incorporated
- Johnson & Johnson
- Insulet Corporation
- Medtronic plc
- Senseonics Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
- Dexcom, Inc.
- A. Menarini Diagnostics
- Echo Therapeutics, Inc.
- GlySens Incorporated
- Johnson & Johnson
- Insulet Corporation
- Medtronic plc
- Senseonics Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/continuous-glucose-monitoring-systems-market-amr
Table Of Content:
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools &
models
CHAPTER 2: EXECUTIVE
SUMMARY
2.1. Key findings of the
study
2.2. CXO Perspective
CHAPTER 3: MARKET
OVERVIEW
3.1. Market definition
3.2. Need for glucose
monitoring systems
3.2.1. Diabetes-a pandemic
3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and
gestational diabetes mellitus (GDM)
3.2.1.4. Gestational
diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare
expenditure on diabetes
3.3. Key Findings
3.3.1. Top investment
pockets
3.3.2. Top winning
strategies
3.3.3. Value Chain
Analysis
3.4. Patent analysis
3.4.1. Patent analysis, by
market participant
3.4.2. U.S. patent analysis,
by market participant
3.4.3. Patent analysis, by
year
3.5. Market Share
Analysis, 2017
3.6. Government
Regulations
3.6.1. FDA regulations
(21CFR820)
3.6.1.1. Objective and
Scope of FDA 21CFR820
3.6.2. ISO regulations
(ISO 13485:2003)
3.6.2.1. Objective and
Scope of ISO 13485:2003
3.7. Reimbursement
Scenario
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Benefits of CGMS
over POC glucometers
3.8.1.2. Rise in incidence
of diabetes cases
3.8.1.3. Technological
advancements
3.8.2. Restraints
3.8.2.1. Adverse effects
and accuracy
3.8.2.2. Reimbursement and
stringent regulatory issues
3.8.3. Opportunities
3.8.3.1. High adoption
rate of CGMS in home healthcare and ICUs
3.8.3.2. Increase in
product awareness
3.8.3.3. High undiagnosed
patient population
3.8.4. Impact analyses
CHAPTER 4: CONTINOUS
GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and
forecast
4.2. Sensors
4.2.1. Key market trends,
growth factors, and opportunities
4.2.2. Market size and
forecast
4.3. Transmitters &
Receivers
4.3.1. Key market trends,
growth factors, and opportunities
4.3.2. Market size and
forecast
4.4. Integrated Insulin
pumps
4.4.1. Key market trends,
growth factors, and opportunities
4.4.2. Market size and
forecast
CHAPTER 5: CONTINUOUS
GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
5.1. Overview
5.1.1. Market size and
forecast
5.2. Adult Population
(>14 years)
5.2.1. Market size and
forecast
5.3. Children Population
(14 years)
5.3.1. Market size and
forecast
CHAPTER 6: CONTINUOUS
GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and
forecast
6.2. Diagnostic
centers/clinics
6.2.1. Market size and
forecast
6.3. ICUs
6.3.1. Market size and
forecast
6.4. Home Healthcare
6.4.1. Market size and
forecast
CHAPTER 7: CONTINUOUS
GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and
forecast
7.2. North America
7.2.1. Key market trends,
growth factors, and opportunities
7.2.2. North America
continuous glucose monitoring systems market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. continuous
glucose monitoring systems market size and forecast, by component
7.2.2.1.2. U.S. continuous
glucose monitoring systems market size and forecast, by demographics
7.2.2.1.3. U.S. continuous
glucose monitoring systems market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada
continuous glucose monitoring systems market size and forecast, by component
7.2.2.2.2. Canada
continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.2.3. Canada
continuous glucose monitoring systems market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico
continuous glucose monitoring systems market size and forecast, by component
7.2.2.3.2. Mexico
continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.3.3. Mexico
continuous glucose monitoring systems market size and forecast, by end user
7.2.3. North America
continuous glucose monitoring systems market size and forecast, by component
7.2.4. North America
continuous glucose monitoring systems market size and forecast, by demographics
7.2.5. North America
continuous glucose monitoring systems market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends,
growth factors, and opportunities
7.3.2. Europe continuous
glucose monitoring systems market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany
continuous glucose monitoring systems market size and forecast, by component
7.3.2.1.2. Germany
continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.1.3. Germany
continuous glucose monitoring systems market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France
continuous glucose monitoring systems market size and forecast, by component
7.3.2.2.2. France
continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.2.3. France
continuous glucose monitoring systems market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK continuous
glucose monitoring systems market size and forecast, by component
7.3.2.3.2. UK continuous
glucose monitoring systems market size and forecast, by demographics
7.3.2.3.3. UK continuous
glucose monitoring systems market size and forecast, by end user
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (516) 300-1215
Comments
Post a Comment